MedPath

The effect of ginger-quince compound on dyspepsia induced by chemotherapy and radiotherapy

Phase 3
Conditions
dyspepsia.
Somatoform autonomic dysfunction
Registration Number
IRCT2013111815436N1
Lead Sponsor
Simorgh-e-Hekmat knowledge-base institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

suffering from cancer; definitely diagnosed by a pathologist; 18?? year-old or more; under chemotherapy treatments; simultaneous radiotherapy treatments inducing ?nausea and vomiting such as whole body or upper abdomen. Exclusion criteria: Warfarin and Heparin ?treatment; ASA consuming more than 80 mg; history of? blood disorders; history of severe thrombocytopenia; allergy to ginger or consuming it during the ?past week; gastro-intestinal cancers; having nausea and vomiting induced by factors except ?chemotherapy or radiotherapy such as CNS tumors, HTN, renal failure or hepatic disorders; gastrointestinal ?problems like gastric or peptic ulcers; forgetting the use of capsules three consecutive times or more.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausa. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.;Vomiting. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.;Bloating. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.;Anorexia. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.;Poor appetite. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.;Postprandial fullness. Timepoint: During the intervention, weekly. Method of measurement: Data registration form.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath